BANGKOK, July 15 (Reuters) – Germany’s BioNTech (22UAy.DE) on Thursday denied it was in talks with Thailand’s Thonburi Healthcare Group Pcl (THG.BK) for a deal to import 20 million doses of the coronavirus vaccine to Thailand.
Thonburi Healthcare Group Pcl (THG.BK) had said it would sign a private order for 20 million doses of the Pfizer(PFE.N)– BioNTech, news of which saw the hospitals operator’s share price leap over 13%.
“We are not in negotiations with the company,” BioNTech said in an e-mailed responding to a Reuters query about the deal. It also denied it was negotiations with any Thai entity.
Company chairman Boon Vanasin had told Reuters a deal would be signed on Thursday, with BioNTech, the German firm that jointly developed the mRNA vaccine with Pfizer. Asked about the denial, Boon said: “We are not doing it directly.”
Pfizer did not respond to a Reuters request for comment.
Read more…
